Pekin Hardy Strauss, Inc. Inmune Bio, Inc. Transaction History
Pekin Hardy Strauss, Inc.
- $744 Million
- Q4 2024
A detailed history of Pekin Hardy Strauss, Inc. transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Pekin Hardy Strauss, Inc. holds 83,350 shares of INMB stock, worth $718,476. This represents 0.05% of its overall portfolio holdings.
Number of Shares
83,350Holding current value
$718,476% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding INMB
# of Institutions
75Shares Held
6.57MCall Options Held
243KPut Options Held
46.4K-
Black Rock Inc. New York, NY813KShares$7.01 Million0.0% of portfolio
-
Praetorian Pr LLC Rincon, PR781KShares$6.73 Million1.64% of portfolio
-
Vanguard Group Inc Valley Forge, PA738KShares$6.36 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$5.14 Million45.87% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL476KShares$4.1 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $155M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...